Optimising Management of Angina
This article has multiple issues. Please help improve it or discuss these issues on the talk page. |
Coronary heart disease (CHD), predominantly due to myocardial infarction (MI), is the number one cause of death in the United Kingdom [1]. However, one of its most common initial manifestations, angina, remains as of yet understudied and its burden may be underappreciated. This is partly due to the fact that diagnosis of stable angina pectoris is based solely on the characterization of the pain as elicited by the doctor. Many patients with typical symptoms of stable angina are not diagnosed as angina and factors such as sex, ethnicity and age may influence the physician’s final recommendations for diagnostic testing such as coronary angiography.
Optimising Management of Angina (OMA) is a cluster randomized controlled trial of a multi-faceted decision support and educational intervention within chest pain clinics across England. OMA looks at ways of improving the care of people suffering with angina as well as exploring the reasons why treatment received varies.
Objectives
- To determine the cumulative impact on patient outcome of missed opportunities for improving patient outcome, from the beginning to the end of the patient journey, across five of the most common symptomatic coronary presentations, assessing inequalities in care and outcome.
- To determine at the level of the individual hospital the extent to which the organisation and processes of care have an impact on the patient journey. We will assess how variations measured at hospital level are impacted by the quality of primary care.
- To establish the effectiveness and cost-effectiveness of a multi-faceted intervention targeting initial specialist management at hospital chest pain clinics of patients early in the symptomatic phase of the patient journey.
- To determine whether novel biomarkers are a cost-effective addition to existing clinical information in predicting the progression of chronic stable angina to acute fatal and non-fatal events.
Collaborators
OMA is a collaboration between:
Funding
OMA is funded by the NHS National Institute of Health Research (NIHR)
External links
[Optimising Management of Angina home page http://omastudy.org.uk/]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This medical article is a stub. You can help ssf by expanding it. |
- Pages with broken file links
- Articles lacking sources from July 2009
- All articles lacking sources
- Wikipedia articles needing context from July 2009
- Wikipedia introduction cleanup from July 2009
- Articles with topics of unclear notability from July 2009
- Articles that need to be wikified from July 2009
- All articles that need to be wikified
- Ischemic heart diseases
- Cardiology
- Medicine stubs
- 2Fix